Efficacy and Safety of Lobeglitazone Versus Sitagliptin
Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Efficacy and Safety of Lobeglitazone versus Sitagliptin in inadequately controlled by
Metformin alone Type 2 Diabetes mellitus Patients with Metabolic syndrome.